Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Common genetic variants and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). | Academic Article |
Why?
|
| Hepatocyte growth factor is associated with progression of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). | Academic Article |
Why?
|
| Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis). | Academic Article |
Why?
|
| Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. | Academic Article |
Why?
|
| Sex differences in subclinical atherosclerosis by race/ethnicity in the multi-ethnic study of atherosclerosis. | Academic Article |
Why?
|
| P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). | Academic Article |
Why?
|
| Loss of p27 phosphorylation at Ser10 accelerates early atherogenesis by promoting leukocyte recruitment via RhoA/ROCK. | Academic Article |
Why?
|
| Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis. | Academic Article |
Why?
|
| Role of interleukin-1 in bacterial atherogenesis. | Academic Article |
Why?
|
| The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus. | Academic Article |
Why?
|
| O'Donnell, Christopher | Person |
Why?
|
| Rifkin, Ian | Person |
Why?
|
| A(3) adenosine receptor deficiency does not influence atherogenesis. | Academic Article |
Why?
|
| Atherogenesis and ischemic heart disease. | Academic Article |
Why?
|
| Basic research in antioxidant inhibition of steps in atherogenesis. | Academic Article |
Why?
|